(2R,3S,4S,5R,6R)-2-(Hydroxymethyl)-6-(nonyloxy)tetrahydro-2H-pyran-3,4,5-triol, 95.0%, 5g

2-((Difluoromethyl)sulfonyl)benzo[d]thiazole, 97%, 10g

4-Acetoxy-2',5'-dichlorobenzophenone, 90.0%, 1g

2-Chloro-5-trifluoromethyl-pyridine-3-sulfonic acid amide, 95.0%, 500mg

2-BROMO-N-CYCLOPROPYL-N-ETHYLACETAMIDE, 95.0%, 250mg

Oxazol-2(3H)-one, 95.0%, 1g

Sodium polytungstate hydrate, min. 99.9%, pa, 250 g, plastic packaging.

(2S,4R)-1-((S)-2-((Cyclopentyloxy)carbonyl)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylic acid, 95.0%, 1g

[(2-methoxy-4,6-dimethyl-3-pyridinyl)methyl]amine, 95.0%, 250mg

6-bromo-N-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 250mg

trans-2-Octen-1-ol>95.0%(GC)100mL

ethyl 2-hydroxy-4-oxo-4-[3-(trifluoromethyl)phenyl]but-2-enoate, 95%, 250mg

(2-Nitrophenyl)(phenyl)methanol, 95.0%, 1g